Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
142.00
-0.50 (-0.35%)
Nov 17, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 14.3 billion as of November 17, 2026. It is the 15,177th most valuable company in the world and the 499th biggest in Taiwan. Its market cap has decreased by 1.04% in one year.
Market Cap
14.30B
Enterprise Value
13.48B
Revenue
1.14B
Global Rank
Country Rank
#499 Taiwan
PE Ratio
30.16
ChartMarket Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 14.30B, an increase of 180.69%. That is a compound annual growth rate of 13.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 14.30B | -0.43% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Steminent Biotherapeutics | 21.07B |
| Sunmax Biotechnology | 20.94B |
| CHO Pharma | 18.19B |
| TaiMed Biologics | 17.40B |
| EirGenix | 15.83B |
| Gongwin Biopharm Holdings | 15.14B |
| Medigen Vaccine Biologics | 14.79B |
| Lumosa Therapeutics | 14.64B |